-+ 0.00%
-+ 0.00%
-+ 0.00%
Changes in Hong Kong stocks | Deshi-B (02526) rose by more than 24% in early trading, iMED-6.0 took the top and runner-up in the international double list Forbes published an article against US stock Tempus AI
Share
Listen to the news

The Zhitong Finance App learned that Deshi-B (02526) rose more than 24% in early trading. As of press release, it rose 24.35% to HK$105.7, with a turnover of HK$62.7362 million.

According to news, Deshi recently released iMediimage 6.0, a sixth-generation general medical imaging model with a completely restructured underlying architecture. In the two most authoritative international MMMU and MedBench VLM evaluation benchmarks, iMED-6.0 both took 1st and 2nd place in the world, completely surpassing GPT-4V, GPT-5.5, Gemini-3.5-Flash, Claopus 4.7 and mainstream domestic general models. The series was posted on overseas social media platforms, and the number of readers of a single post in less than 24 hours after it went live has already surpassed 853,000.

Notably, the authoritative international financial media “Forbes” recently published an in-depth article entitled “How China's Medical AI Can Win Back the Market”, listing Deshi Technology as the core litmus test for revaluing China's medical AI, and closely benchmarking it with Tempus AI, the leading medical AI company that surged 90% in US stocks this year. “Forbes” emphasizes that Deshi Technology is building a “Microsoft Office for the medical AI industry” through the zero-code platform iMedloop.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending